07:00 | OBD | Interim Results | RNS |
27.06.2025 13:30 | OBD | Holding(s) in Company | RNS |
09.05.2025 07:00 | OBD | OBD’s Oxford Lab accredited by UKAS | Reach |
10.04.2025 16:10 | OBD | Director/PDMR Shareholding | RNS |
02.04.2025 07:00 | OBD | PDMR Dealing | RNS |
28.03.2025 10:35 | OBD | Result of AGM | RNS |
17.03.2025 07:00 | OBD | Board Changes | RNS |
14.03.2025 17:25 | OBD | Holding(s) in Company | RNS |
13.03.2025 16:45 | OBD | Oxford BioDynamics expands UK insurance partnership with Bupa | Alliance |
13.03.2025 07:00 | OBD | Expansion of OBD/Bupa UK insurance partnership | Reach |
05.03.2025 16:00 | OBD | Publication of 2024 Annual Report | RNS |
03.03.2025 07:00 | OBD | PDMR Dealing / Grant of Share Options | RNS |
28.02.2025 16:10 | OBD | Oxford Biodynamics shares dive as loss widens despite revenue rise | Alliance |
28.02.2025 10:58 | BMK, OBD, ROAD | AIM WINNERS & LOSERS: Oxford BioDynamics and Benchmark slump | Alliance |
28.02.2025 07:00 | OBD | Preliminary Results and Notice of AGM | RNS |
21.02.2025 12:37 | SXS, RMV, BBOX | UK earnings, trading statements calendar - next 7 days | Alliance |
21.02.2025 10:00 | OBD | Notice of Preliminary Results | RNS |
17.02.2025 13:07 | OBD | Holding(s) in Company | RNS |
12.02.2025 16:48 | OBD | Holding(s) in Company | RNS |
12.02.2025 14:00 | OBD | Oxford BioDynamics inks distribution deal with Romanian medical firm | Alliance |
12.02.2025 07:00 | OBD | OBD partners with Regina Maria in Romania | Reach |
10.02.2025 12:09 | OBD | Holding(s) in Company | RNS |
06.02.2025 13:43 | OBD | Holding(s) in Company | RNS |
06.02.2025 10:46 | OBD | Holding(s) in Company | RNS |
06.02.2025 07:00 | OBD | Holding(s) in Company | RNS |
05.02.2025 14:13 | OBD | Holding(s) in Company | RNS |
05.02.2025 14:11 | OBD | Holding(s) in Company | RNS |
05.02.2025 11:01 | AXL, OBD, MTEC | AIM WINNERS & LOSERS: Arrow Exploration well disappoints | Alliance |
05.02.2025 07:00 | OBD | CRC Test Accurately Detects Cancer and Polyps | Reach |
04.02.2025 14:38 | OBD | Holding(s) in Company | RNS |
31.01.2025 12:00 | OBD | Result of GM and Director Dealings | RNS |
23.01.2025 07:00 | OBD | CiRT: Real World Data Presented at ASCO-GI | Reach |
17.01.2025 21:43 | OBD | IN BRIEF: Oxford BioDynamics raises GBP350,000 via retail offer | Alliance |
17.01.2025 07:00 | OBD | Result of WRAP Retail Offer | RNS |
15.01.2025 07:00 | OBD | Result of Placing and Subscription | RNS |
14.01.2025 21:20 | OBD | IN BRIEF: Oxford BioDynamics launches GBP6.5 million fund raise | Alliance |
14.01.2025 17:09 | OBD | WRAP Retail Offer | RNS |
14.01.2025 16:35 | OBD | Proposed Fundraising | RNS |
24.12.2024 07:00 | OBD | Issue of shares, Director / PDMR holdings and TVR | RNS |
19.12.2024 14:41 | OBD | Shareholder Loan and Related Party Transaction | RNS |
16.12.2024 07:00 | OBD | Directorate Change, Funding Update & Joint Broker | RNS |
06.12.2024 16:05 | OBD | Holding(s) in Company | RNS |
03.12.2024 16:41 | OBD | Response to Share Price Movement | RNS |
29.11.2024 11:40 | OBD | Director/PDMR Shareholding | RNS |
28.10.2024 12:12 | OBD | Director / PDMR holdings and Total Voting Rights | RNS |
25.10.2024 07:00 | OBD | Prognostic Covid Severity Test Study Published | Reach |
22.10.2024 13:00 | OBD | CiRT Receives Clinical Approval from NYS CLEP | Reach |
15.10.2024 14:34 | OBD | Holding(s) in Company | RNS |
14.10.2024 15:34 | OBD | Oxford BioDynamics pledges to cut costs amid need to raise extra funds | Alliance |
14.10.2024 07:00 | OBD | Commercial update for FY24 | RNS |
07.10.2024 07:01 | OBD | Holding(s) in Company | RNS |
07.10.2024 07:00 | OBD | CIRRP Award Update | RNS |
11.09.2024 12:55 | OBD | Holding(s) in Company | RNS |
22.08.2024 16:59 | OBD | Holding(s) in Company | RNS |
22.08.2024 11:41 | OBD | Holding(s) in Company | RNS |